Torsade de pointes in patients on chronic amiodarone treatment: Contributing factors and drug interactions

Dante Antonelli, Shaul Atar, Nahum A. Freedberg, Tiberio Rosenfeld

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Background: Torsade de pointes is rarety associated with chronic amiodarone treatment, despite the effect of amiodarone on QT interval prolongation. Objective: To identify risk factors and associated conditions that may cause TdP in patients on chronic amiodarone treatment. Methods: We reviewed the data of six consecutive patients on chronic amiodarone treatment who were admitted to the intensive cardiac care unit due to syncope and TdP. Results: The patients' median age was 73.5 years, and five were women. Concomitantly, loratadine was given to two patients and trazodone to one patient. Associated and attributing conditions to the development of TdP were hypokalemia in three patients, drug-induced bradycardia in one and reduced left ventricular function in four. Conclusions: TdP associated with chronic amiodarone treatment may occur when amiodarone is co-administered with drugs that may potentially prolong QT interval. Additional risk factors for amiodarone-associated TdP include female gender, hypokalemia, reduced left ventricular function and bradycardia.

Original languageEnglish
Pages (from-to)163-165
Number of pages3
JournalIsrael Medical Association Journal
Issue number3
StatePublished - Mar 2005
Externally publishedYes


  • Amiodarone
  • Arrhythmia
  • Hypokalemia
  • QT interval
  • Torsade de pointes


Dive into the research topics of 'Torsade de pointes in patients on chronic amiodarone treatment: Contributing factors and drug interactions'. Together they form a unique fingerprint.

Cite this